{
    "id": "5c928afeecadf2e73f000018",
    "question": "Can cardiospheres be produced from skin fibroblasts?",
    "options": {
        "A": "yes",
        "B": "no"
    },
    "answer": "A",
    "predict": "{\"step_by_step_thinking\": \"To answer this question, we need to understand the process of generating cardiospheres from skin fibroblasts. Cardiospheres are three-dimensional aggregates of cardiac cells that can be used to study cardiac function and develop new therapies for heart disease. The process typically involves the use of specific growth factors and culture conditions to induce the differentiation of fibroblasts into cardiac cells. Given the information provided in the documents, we can see that fibroblasts can be induced to differentiate into various cell types, including cardiac cells, through the use of specific transcription regulators. Therefore, it is plausible that skin fibroblasts can be induced to form cardiospheres. In fact, the document mentions that fibroblasts can be forced to express specific factors to convert them into heart muscle cells, which suggests that they can also be induced to form cardiospheres. The key to answering this question is to understand that cardiospheres are a type of cellular aggregate that can be generated from various cell types, including fibroblasts, through the use of specific growth factors and culture conditions. Based on this understanding, the answer to the question is that cardiospheres can indeed be produced from skin fibroblasts.\", \"answer_choice\": \"A\"}",
    "snippets": [
        {
            "id": "Cell_Biology_Alberts_6330",
            "title": "Cell_Biology_Alberts",
            "content": "Where a disease has a genetic cause, we can derive iPS cells from sufferers and use these cells to produce the specific cell types that malfunction, to investigate how the malfunction occurs, and to screen for drugs that might help to put it right. Timothy syndrome provides an example. In this rare genetic condition, there is a severe, life-threatening disorder in the rhythm of the heart beat (as well as several other abnormalities), as a result of a mutation in a specific type of Ca2+ channel. To study the underlying pathology, researchers took skin fibroblasts from patients with the disorder, generated iPS cells from the fibroblasts, and drove the iPS cells to differentiate into heart muscle cells. These cells, when compared with heart muscle cells prepared similarly from normal control individuals, showed irregular contractions and abnormal patterns of Ca2+ influx and electrical activity that could be characterized in detail. From this finding, it is a small step to development of"
        },
        {
            "id": "Cell_Biology_Alberts_6171",
            "title": "Cell_Biology_Alberts",
            "content": "Fibroblasts Change their Character in Response to Chemical and physical Signals Fibroblasts seem to be the least specialized cells in the connective-tissue family. They are dispersed in connective tissue throughout the body, where they secrete a nonrigid extracellular matrix that is rich in type I or type III collagen, or both, as discussed in Chapter 19. When a tissue is injured, the fibroblasts nearby proliferate, migrate into the wound (Movie 22.1), and produce large amounts of collagenous matrix that helps to isolate and repair the damaged tissue. Their ability to thrive in the face of injury, together with their solitary lifestyle, may explain why fibroblasts are the easiest of cells to grow in culture\u2014a feature that has made them a favorite subject for cell biological studies."
        },
        {
            "id": "Cell_Biology_Alberts_5310",
            "title": "Cell_Biology_Alberts",
            "content": "Figure 19\u201343 The shaping of the extracellular matrix by cells. this micrograph shows a region between two pieces of embryonic chick heart (rich in fibroblasts as well as heart muscle cells) that were cultured on a collagen gel for 4 days. a dense tract of aligned collagen fibers has formed between the explants, presumably as a result of the fibroblasts in the explants tugging on the collagen. (From D. Stopak and a.K. harris, Dev. Biol. 90:383\u2013398, 1982. With permission from academic press.)"
        },
        {
            "id": "Cell_Biology_Alberts_6168",
            "title": "Cell_Biology_Alberts",
            "content": "FibRoblaStS and theiR tRanSFoRmationS: the ConneCtive-tiSSue Cell Family From epithelia, with their varied patterns of renewal and their enormous variety of protective, absorptive, secretory, sensory, and biosynthetic functions, we turn now to connective tissues. Connective tissues typically consist of cells dispersed in extracellular matrix that they themselves secrete, as discussed in Chapter 19. They originate from the mesodermal (middle) layer of the early embryo, sandwiched between ectoderm and endoderm (see Chapter 21, Figure 21\u20133)."
        },
        {
            "id": "Cell_Biology_Alberts_6326",
            "title": "Cell_Biology_Alberts",
            "content": "and make collagenous matrix so as to replace the lost muscle with a fibrous scar. This is a poor sort of repair. By forcing expression of the appropriate factors in the heart, as described above, it has proved possible, in the mouse at least, to do better than nature and regenerate lost heart muscle by transdifferentiation of heart fibroblasts."
        },
        {
            "id": "Cell_Biology_Alberts_6172",
            "title": "Cell_Biology_Alberts",
            "content": "Figure 22\u201311 The family of connective-tissue cells. arrows show the interconversions that are thought to occur within the family. For simplicity, the fibroblast is shown as a single cell type, but it is uncertain how many types of fibroblasts exist and whether the differentiation potential of different types is restricted in different ways."
        },
        {
            "id": "Pathology_Robbins_942",
            "title": "Pathology_Robbins",
            "content": "EXTERNAL STIMULI? GENETIC SUSCEPTIBILITY EXTERNAL STIMULI? Fig. 5.28 Amodelforthepathogenesisofsystemicsclerosis.Unknownexternalstimulicausevascularabnormalitiesandimmuneactivationingeneticallysusceptibleindividuals,andbothcontributetotheexcessivefibrosis.Endothelial injury Pulmonary arterial hypertension Synthesis of extracellular matrix proteins: fibrosis involving skin and parenchymal organs Ischemia, repair Proliferative and obliterative vasculopathy Tand B-cell activation Production of pro-fibrotic cytokines (e.g., TGF-\u02dc, IL-13, PDGF) Autoantibodies T B activated macrophages, actions of fibrogenic cytokines produced by infiltrating leukocytes, hyperresponsiveness of fibroblasts to these cytokines, and scarring following ischemic damage caused by the vascular lesions. Studies with cultured fibroblasts from patients have suggested an intrinsic abnormality that causes the cells to produce excessive amounts of collagen."
        },
        {
            "id": "InternalMed_Harrison_18310",
            "title": "InternalMed_Harrison",
            "content": "The cardiomyocyte is no longer considered a terminally differentiated cell and possesses regenerative capacity. Such renewal is accelerated under conditions of stress and injury, such as an ischemic event or 1515 heart failure. Investigations that use either bone marrow\u2013derived precursor cells or autologous cardiac-derived cells have gained traction. A number of smalland moderate-scale trials of such therapy have focused on post\u2013myocardial infarction patients and have used autologous bone marrow\u2013derived progenitor or stem cells. These trials have had variable results, with most demonstrating modest improvements in parameters of cardiac structure and remodeling. More promising, however, are cardiac-derived stem cells. Two preliminary pilot trials delivering cells via an intracoronary approach have been reported. In one, autologous c-kit\u2013positive cells isolated from the atria obtained from patients undergoing CABG were cultured and rein-fused. In another, cardiosphere-derived cells"
        },
        {
            "id": "Cell_Biology_Alberts_6325",
            "title": "Cell_Biology_Alberts",
            "content": "An elegant example comes from studies of the heart. By forcing expression of an appropriate combination of factors\u2014not Oct4, Sox2, Klf4, and Myc, but Gata4, Mef2c, and Tbx5\u2014it is possible to convert heart fibroblasts directly into heart muscle cells. This has been done in the living mouse, using retroviral vectors, and the transformation occurs with high efficiency when the vectors carrying the transgenes are injected directly into the heart muscle tissue itself. Although they occupy only a small fraction of the tissue volume, the fibroblasts in the heart outnumber the heart muscle cells, and they survive in large numbers even where the heart muscle cells have died. Thus, in a typical nonfatal heart attack, where heart muscle cells have died for lack of oxygen, the fibroblasts proliferate and make collagenous matrix so as to replace the lost muscle with a fibrous scar. This is a poor sort of repair. By forcing expression of the appropriate factors in the heart, as described above, it"
        },
        {
            "id": "Cell_Biology_Alberts_1890",
            "title": "Cell_Biology_Alberts",
            "content": "Specialized Cell types Can Be experimentally reprogrammed to Become pluripotent Stem Cells Manipulation of transcription regulators can also coax various differentiated cells to de-differentiate into pluripotent stem cells that are capable of giving rise to the different cell types in the body, much like the embryonic stem (ES) cells discussed in Chapter 22. When three specific transcription regulators are artificially expressed in cultured mouse fibroblasts, a number of cells become induced pluripotent stem cells (iPS cells)\u2014cells that look and behave like the pluripotent ES cells that are derived from embryos (Figure 7\u201336). This approach has been adapted to produce iPS cells from a variety of specialized cell types, including cells taken from humans. Such human iPS cells can then be directed to generate a population of differentiated cells for use in the study or treatment of disease, as we discuss in Chapter 22."
        },
        {
            "id": "InternalMed_Harrison_18311",
            "title": "InternalMed_Harrison",
            "content": "have been reported. In one, autologous c-kit\u2013positive cells isolated from the atria obtained from patients undergoing CABG were cultured and rein-fused. In another, cardiosphere-derived cells grown from endomyocardial biopsy specimens were used. These small trials demonstrated improvements in left ventricular function but require far more work to usher in a clinical therapeutic success. The appropriate route of administration, the quantity of cells to achieve a minimal therapeutic threshold, the constitution of these cells (single source or mixed), the mechanism by which benefit accrues, and shortand long-term safety remain to be elucidated."
        },
        {
            "id": "Cell_Biology_Alberts_5309",
            "title": "Cell_Biology_Alberts",
            "content": "If two small pieces of embryonic tissue containing fibroblasts are placed far apart on a collagen gel, the intervening collagen becomes organized into a compact band of aligned fibers that connect the two explants (Figure 19\u201343). The fibroblasts subsequently migrate out from the explants along the aligned collagen fibers. Thus, the fibroblasts influence the alignment of the collagen fibers, and the collagen fibers in turn affect the distribution of the fibroblasts. Fibroblasts may have a similar role in organizing the extracellular matrix inside the body. First they synthesize the collagen fibrils and deposit them in the correct orientation. Then they work on the matrix they have secreted, crawling over it and tugging on it so as to create tendons and ligaments and the tough, dense layers of connective tissue that surround and bind together most organs."
        },
        {
            "id": "Cell_Biology_Alberts_1885",
            "title": "Cell_Biology_Alberts",
            "content": "The importance of combinations of transcription regulators for the specification of cell types is most easily demonstrated by their ability\u2014when expressed artificially\u2014to convert one type of cell to another. Thus, the artificial expression of three neuron-specific transcription regulators in liver cells can convert the liver cells into functional nerve cells (Figure 7\u201334). In some cases, expression of even a single transcription regulator is sufficient to convert one cell type to another. For example, when the gene encoding the transcription regulator MyoD is artificially introduced into fibroblasts cultured from skin connective tissue, the fibroblasts form muscle-like cells. As discussed in Chapter 22, fibroblasts, which are derived from the same broad class of embryonic cells as muscle cells, have already accumulated many of the other necessary transcription regulators required for the"
        },
        {
            "id": "InternalMed_Harrison_5451",
            "title": "InternalMed_Harrison",
            "content": "The original model for tissue engineering focused largely on the isolation of tissue from the organ of interest, the growth and expansion of the tissue-specific cells, and the seeding of these cells onto three-dimensional scaffolds. Just a few decades ago, most primary cultures of human cells could not be grown and expanded in large quantities, representing a major impediment to the engineering of human tissues. However, the identification of specific tissue progenitor cells in the 1990s allowed expansion of multiple cell types, and progress has occurred steadily since then. Some cell types are more amenable to expansion than others, reflecting in part their native regenerative capacity but also varying requirements for nutrients, growth factors, and cell\u2013cell contacts. As an example of progress, after years of effort, protocols for the growth and expansion of human cardiomyocytes are now available. However, there are still many tissue-specific cell types that cannot be expanded from"
        },
        {
            "id": "Cell_Biology_Alberts_5301",
            "title": "Cell_Biology_Alberts",
            "content": "Many proteins appear to have evolved by repeated duplications of an original DNA sequence, giving rise to a repetitive pattern of amino acids. The genes that encode the \u03b1chains of most of the fibrillar collagens provide a good example: they are very large (up to 44 kilobases in length) and contain about 50 exons. Most of 1.5 nm Figure 19\u201340 A fibroblast surrounded by collagen fibrils in the connective tissue of embryonic chick skin. In this electron micrograph, the fibrils are organized into bundles that run approximately at right angles to one another. therefore, some bundles are oriented longitudinally, whereas others are seen in cross section. the collagen fibrils are produced by fibroblasts. (From C. ploetz, E.I. Zycband and"
        },
        {
            "id": "InternalMed_Harrison_29668",
            "title": "InternalMed_Harrison",
            "content": "A major advance has been the development of induced pluripotent stem cells. Using this technique, adult somatic cells such as skin fibroblasts are treated with four pluripotency factors (SOX2, KLF4, cMYC, and Oct4), and this generates induced pluripotent stem cells (iPSCs). These adult-derived stem cells sidestep the ethical issues of using stem cells derived from human embryos. The development of these cells has tremendous promise for both studying disease mechanisms and testing therapeutics. As yet there is no consensus on the best way to generate and differentiate the iPSCs; however, techniques to avoid using viral vectors and use of Cre-lox systems to remove reprogramming factors result in a better match of gene expression profiles with those of embryonic stem cells. Over the years, the field of directed differentiation has used three main strategies to specify neural lineages from human pluripotent stem cells. These strategies are embryoid body formation, coculture on"
        },
        {
            "id": "Cell_Biology_Alberts_6322",
            "title": "Cell_Biology_Alberts",
            "content": "these cells can be cultured indefinitely as pluripotent cells when attached as a monolayer to a dish. alternatively they can be detached and allowed to form aggregates called embryoid bodies, which causes the cells to begin to specialize. Cells from embryoid bodies, cultured in media with different factors added, can then be driven to differentiate in various ways. (based on e. Fuchs and J.a. Segre, Cell 100:143\u2013155, 2000. with permission from elsevier.) macrophage colony-interleukin-3, stimulating factor, interleukin-1 macrophage iPS cells (about 1,000 cells) dibutyryl cAMP, retinoic acid smooth muscle cell fbroblast fbroblast fbroblast growth factor 2, growth factor 2, growth epidermal platelet-derived factor growth factor growth factor 1258 Chapter 22: Stem Cells and tissue Renewal aggregate of hollow ball of budding of optic vesicle invaginates cultured ES cells neural cells optic vesicle to form optic cup (B) 100 \u00b5m"
        },
        {
            "id": "Cell_Biology_Alberts_6301",
            "title": "Cell_Biology_Alberts",
            "content": "Fibroblasts Can be Reprogrammed to Create induced pluripotent Stem Cells (ipS Cells)"
        },
        {
            "id": "InternalMed_Harrison_5376",
            "title": "InternalMed_Harrison",
            "content": "cell populations, such as bone marrow mesenchymal stem cells (MSCs), CD34+ hematopoietic stem cells (HSCs), cardiac mesenchymal cells, and adipose-derived stem cells (ASCs), for use in regenerative strategies. Tissue culture evidence suggests that these stem cell populations may be able to generate differentiated cell types unrelated to their organ source (including myocytes, chondrocytes, tendon cells, osteoblasts, cardiomyocytes, adipocytes, hepatocytes, and neurons) in a process known as transdifferentiation. However, it is still unclear whether these stem cells are capable of generating differentiated cell types that integrate into organs, survive, and function after transplantation in vivo. A number of early studies of MSCs transplanted into heart, liver, and other organs suggested that the cells had differentiated into organ-specific cell types with beneficial effects in animal models of disease. Unfortunately, subsequent studies revealed that the stem cells had simply fused"
        },
        {
            "id": "InternalMed_Harrison_5381",
            "title": "InternalMed_Harrison",
            "content": "types might have the potential to engraft and generate cardiomyocytes. However, most investigators have found that the generation of new cardiomyocytes by these cells is at best a rare event and that graft survival over long periods is poor. The preponderance of evidence suggests that the observed beneficial effects of most experimental therapies were not derived from direct stem cell generation of cardiomyocytes but rather from indirect effects of the stem cells on resident cells. It is not clear whether these effects reflect the release of soluble trophic factors, the induction of angiogenesis, the release of anti-inflammatory cytokines, or another mechanism. A wide variety of cell delivery methods, cell types, and cell doses have been used in a progressively enlarging series of clinical trials, but the fate of the cells and the mechanisms by which they alter cardiac function are still open questions. In aggregate, however, these studies have shown a small but measurable improvement"
        },
        {
            "id": "InternalMed_Harrison_5452",
            "title": "InternalMed_Harrison",
            "content": "after years of effort, protocols for the growth and expansion of human cardiomyocytes are now available. However, there are still many tissue-specific cell types that cannot be expanded from tissue sources, including the pancreas, liver, and nerves. The discovery of pluripotent or highly multipotent stem cells (Chap. 88) may ultimately allow most human cell types to be used for tissue engineering. The stem cell characteristics depend on their origin and their degree of plasticity, with cells from the earliest developmental stages, such as embryonic stem cells, having the greatest plasticity. Induced pluripotent stem cells have the advantage that they can be derived from individual patients, allowing autologous transplants. They can also be differentiated, in vitro, along cell-specific lineages, although these protocols are still at an early stage of development. Human embryonic and induced pluripotent stem cells have a very high replicative potential, but they also have the potential"
        },
        {
            "id": "Surgery_Schwartz_1836",
            "title": "Surgery_Schwartz",
            "content": "skin graft donor sites or in superficial second-degree burns, then repair consists primarily of reepithelialization with minimal or no fibroplasia and granulation tissue formation. The stimuli for reepithelialization remain incompletely defined; however, it appears that the process is mediated by a combination of a loss of contact inhibition; exposure to constituents of the extracel-lular matrix, particularly fibronectin; and cytokines produced by immune mononuclear cells.24,25 In particular EGF, TGF-\u03b2, basic fibroblast growth factor (bFGF), PDGF, and IGF-1 have been shown to promote epithelialization.Role of Growth Factors in Normal HealingGrowth factors and cytokines are polypeptides produced in nor-mal and wounded tissue that stimulate cellular migration, pro-liferation, and function. They often are named for the cells from which they were first derived (e.g., platelet-derived growth fac-tor, PDGF) or for their initially identified function (e.g., fibro-blast growth factor, FGF)."
        },
        {
            "id": "Cell_Biology_Alberts_5510",
            "title": "Cell_Biology_Alberts",
            "content": "invade, and the tumor becomes dependent on its particular stromal cells. Experiments using mice indicate that the growth of some transplanted carcinomas depends on the tumor-associated fibroblasts and normal fibroblasts will not do. Such environmental requirements help to protect us from cancer, as we discuss next in considering the critical phenomenon called metastasis."
        },
        {
            "id": "Pathology_Robbins_534",
            "title": "Pathology_Robbins",
            "content": "Fig. 3.24 Steps in repair by scar formation: healing of a large wound in the skin. This is an example of healing by second intention. (A) Hemostatic plug and inflammation. (B) Proliferation of epithelial cells; formation of granulation tissue by vessel growth and proliferating fibroblasts. (C) Remodeling to produce the fibrous scar. inflammation resolves; how this inflammatory flame is extinguished in most situations of injury is still not well defined. Cell proliferation. In the next stage, which takes up to 10 days, several cell types, including epithelial cells, endothelial and other vascular cells, and fibroblasts, proliferate and migrate to close the now-clean wound. Each cell type serves unique functions. Epithelial cells respond to locally produced growth factors and migrate over the wound to cover it."
        },
        {
            "id": "Pathology_Robbins_2529",
            "title": "Pathology_Robbins",
            "content": "Besides self-renewal, these cardiac stem cells can generate all cell lineages seen within the myocardium. They have a slow intrinsic rate of proliferation, which is greatest in neonates and decreases with age. Of interest, stem cell numbers and progeny also increase after myocardial injury or hypertrophy, albeit to a limited extent, since hearts that suffer an MI clearly do not recover any significant function in the necrotic zone. Nevertheless, the potential for stimulating the proliferation of these cells in vivo is tantalizing because it could facilitate recovery of myocardial function after acute MI or chronic IHD. Ex vivo expansion and subsequent administration of such cells after an MI is another area of vigorous investigation. Unfortunately, results thus far have been less than exciting. Inthevastmajorityofcases,cardiacischemiaisduetocoronaryarteryatherosclerosis;vasospasm,vasculitis,andembolismarelesscommoncauses."
        },
        {
            "id": "InternalMed_Harrison_5375",
            "title": "InternalMed_Harrison",
            "content": "Organ-Specific Multipotent Stem Cells Organ-specific multipotent stem cells have the advantage of already being somewhat specialized so that the inducement of desired cell types may be easier. Cells potentially could be obtained from the patient and amplified in cell culture, circumventing the problems associated with immune rejection. Stem cells are relatively easy to harvest from some tissues, such as bone marrow and blood, but are difficult to harvest from other tissues, such as heart and brain. Moreover, these populations of cells are more limited in potentiality than are pluripotent ES or iPS cells, and they may be difficult to obtain in large quantities from many organs. Therefore, substantial efforts have been devoted to developing techniques for using more easily obtainable stem cell populations, such as bone marrow mesenchymal stem cells (MSCs), CD34+ hematopoietic stem cells (HSCs), cardiac mesenchymal cells, and adipose-derived stem cells (ASCs), for use in regenerative"
        },
        {
            "id": "InternalMed_Harrison_5307",
            "title": "InternalMed_Harrison",
            "content": "Neural stem cells (NS, NSC) Fetal and adult brain (subventricular zone, ventricular zone, and hippo-campus) (m, h) Unrestricted somatic stem cells Mononuclear fraction of cord blood (USSC) (h) Epistem cells (EpiSC) Early postimplantation epiblast (m) Induced pluripotent stem cells (iPS, Variety of terminally differentiated iPSC) cells and tissue stem cells (m, h) Lung stem cells Lung (m, h) Amniotic fluid-derived stem (AFS) Amniotic fluid (m, h) cells Umbilical cord blood stem cells Umbilical cord (h) Adipose stem cells (AST) Fat (m, h) Cardiac stem cells Heart (m, h) Renal stem cells Renal papilla (m, h) Crypt stem cells Intestine (m, h) Colon stem cells (CoSC) Colon (m, h) Hepatic stem cells Liver (m, h) Dental pulp stem cells (DPSC) Dental pulp (m, h) Hair follicle stem cells Hair (m, h) Abbreviations: h, human; m, mouse. identical daughter cells. For stem cells to proliferate in vitro, they must divide symmetrically."
        },
        {
            "id": "InternalMed_Harrison_25348",
            "title": "InternalMed_Harrison",
            "content": "In addition to tissue-resident fibroblasts and transformation of epithelial cells into fibroblasts, bone marrow\u2013derived circulating mesenchymal progenitor cells also contribute to fibrosis. The factors that regulate the differentiation of mesenchymal progenitor cells and their trafficking from the circulation into lesional tissue are unknown. Epithelial and endothelial cells, mesenchymal progenitor cells, and tissuefibroblastscandifferentiateintosmooth-muscle-likemyofibroblasts. Although myofibroblasts can be detected transiently during normal wound healing, they persist in fibrotic tissue, possibly due to resistance toapoptosis,andcontributetoscarformationviaproductionofcollagen and TGF-\u03b2 and contraction of the surrounding extracellular matrix."
        },
        {
            "id": "Pathology_Robbins_535",
            "title": "Pathology_Robbins",
            "content": "Epithelial cells respond to locally produced growth factors and migrate over the wound to cover it. Endothelial and other vascular cells proliferate to form new blood vessels, a process known as angiogenesis. Because of the importance of this process in physiologic host responses and in many pathologic conditions, it is described in more detail later. Fibroblasts proliferate and migrate into the site of injury and lay down collagen fibers that form the scar. The combination of proliferating fibroblasts, loose connective tissue, new blood vessels and scattered chronic inflammatory cells, forms a type of tissue that is unique to healing wounds and is called granulation tissue. This term derives from its pink, soft, granular gross appearance, such as that seen beneath the scab of a skin wound."
        },
        {
            "id": "InternalMed_Harrison_5454",
            "title": "InternalMed_Harrison",
            "content": "Stem cells can be derived from autologous or heterologous sources. Heterologous cells can be used when only temporary coverage is needed, such as replacing skin after a burn or wound. However, if a more permanent construct is required, autologous cells are preferred to avoid rejection. There are also practical issues related to tissue sources. For example, if a patient presents with end-stage heart disease, obtaining a cardiac tissue biopsy for cell expansion is unlikely to be feasible, and bone marrow\u2013derived mesenchymal cells may provide an alternative."
        },
        {
            "id": "InternalMed_Harrison_5463",
            "title": "InternalMed_Harrison",
            "content": "2. A more recent strategy in tissue engineering involves the use of proteins, cytokines, genes, or small molecules that induce in situ Level 4 Heart, kidney, liver, lung Strategies for tissue and organ engineering. tissue regeneration, either alone or with the use of scaffolds. For example, gene transcription factors used in the mouse pancreas led to tissue regeneration. Surgically implanted decellularized heart valve scaffolds, coated with proteins that attract vascular stem cells, led to the creation of in situ cell-seeded functional heart valves in sheep. Drugs that induce muscle regeneration are being tested clinically. Small molecules that induce tissue regeneration are currently under investigation for multiple applications, including growth of skin and hair and for musculoskeletal applications. 3."
        },
        {
            "id": "Pathology_Robbins_938",
            "title": "Pathology_Robbins",
            "content": "The cause of systemic sclerosis is not known, but the disease likely results from three interrelated processes\u2014 autoimmune responses, vascular damage, and collagen deposition ( Fig. 5.28 Autoimmunity. It is proposed that CD4+ T cells responding to an as yet unidentified antigen accumulate in the skin and release cytokines that activate inflammatory cells and fibroblasts. Although inflammatory infiltrates in the affected skin typically are sparse, they include activated CD4+ TH2 cells. Several cytokines, including IL-13 produced by TH2 cells and TGF-\u03b2 produced by macrophages and other cell types, stimulate synthesis of collagen and extracellular matrix proteins (e.g., fibronectin) in fibroblasts. Other cytokines recruit leukocytes and propagate the chronic inflammation."
        }
    ],
    "scores": [
        0.03793110535618859,
        0.032346065229121986,
        0.026718401065657725,
        0.02611982887212245,
        0.0260119940029985,
        0.02591835363453989,
        0.0232972027972028,
        0.022824864712910252,
        0.021861686226004214,
        0.02096617442887795,
        0.02062078034444767,
        0.020324568690234385,
        0.020116597318059818,
        0.019327731092436976,
        0.01886960391633289,
        0.018637309292649097,
        0.017721320473614053,
        0.017534577885269444,
        0.01745598057073467,
        0.017424242424242425,
        0.016653182308522113,
        0.016421024295040044,
        0.016333826429980276,
        0.016285153695225638,
        0.01605126253013577,
        0.01598481136697697,
        0.01568986568986569,
        0.015512265512265512,
        0.01544335536813312,
        0.015365470973326842,
        0.015298175344904316,
        0.015277334185031407
    ]
}